Fierce Pharma Biopharma News & Insights
4 days ago · Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
The top 10 vaccine companies worldwide - Fierce Pharma
What a difference five years—and a global pandemic—can make in reshaping an industry. When Fierce Pharma last published our rankings of the top vaccine players back in 2017, we highlighted the ...
The top 20 drugs by worldwide sales in 2023 | Fierce Pharma
May 28, 2024 · In 2023, Keytruda’s sales grew 21% at constant exchange rates, reaching $25 billion. At the same time, as GLP-1 diabetes and obesity drugs take the world by storm, Novo Nordisk’s semaglutide ...
Pharma | Fierce Pharma
4 days ago · The FDA has approved Pfizer's Hympavzi, an anti-tissue factor pathway inhibitor for patients age 12 and older with hemophilia A or B. Kevin Dunleavy Oct 11, 2024 4:20pm. Connect. The Team. Advertise.
Teva launches first U.S. generic Cialis as Eli Lilly braces for loss of ...
Sep 28, 2018 · It’s time to say goodbye to the bathtub couples who've been a staple of direct-to-consumer drug advertising since 2003—and who helped turn Eli Lilly’s erectile dysfunction drug Cialis into a ...
Rising Pharmaceuticals opens manufacturing plant at former …
Sep 20, 2023 · Rising bought the production facility for $1.2 million and the packaging site for $50,000 in June, according to the Herald & Review.About 30 workers have been hired with an eventual target of 75 ...
Top 20 pharma companies by 2023 revenue - Fierce Pharma
Apr 15, 2024 · There were changes at the top and the bottom of last year’s top 20 pharma rankings by revenue. And, in between, Novo Nordisk made a significant leap, jumping five spots propelled by skyrocketing ...
Pfizer eyes 8 blockbuster cancer drugs in new oncology plan
Feb 29, 2024 · Pfizer fleshes out oncology strategy, targeting 8 blockbuster cancer drugs by 2030. In what CEO Albert Bourla, Ph.D., called an update to a top priority at Pfizer, the company on Thursday ...
The Adderall supply squeeze in the US is growing - Fierce Pharma
Aug 30, 2022 · Sandoz, for its part, has run into problems with 15-mg and 20-mg doses. The growing supply hitch comes about a month after the production squeeze on Teva’s 20-mg and 30-mg Adderall tablets came ...
Quviviq Approved by FDA for Insomnia | Fierce Pharma
Jan 10, 2022 · The FDA blessed Idorsia's Quviviq (daridorexant), a sleeping pill for those with insomnia. Because the FDA has recommended Idorsia to register Quviviq as a controlled substance, the treatment will ...